Decorrelation Time Mapping as an Analysis Tool for Nanobubble-Based Contrast Enhanced Ultrasound Imaging
IEEE Transactions on Medical Imaging · 2024
DOI: 10.1109/tmi.2024.3364076 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE Transactions on Medical Imaging, 2024. Verfasst von Dana Wegierak und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Contrast Media, Prostatic Neoplasms, Ultrasonography. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIBIB NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Nanobubbles (NBs; ~100-500 nm diameter) are preclinical ultrasound (US) contrast agents that expand applications of contrast enhanced US (CEUS). Due to their sub-micron size, high particle density, and deformable shell, NBs in pathological states of heightened vascular permeability (e.g. in tumors) extravasate, enabling applications not possible with microbubbles (~1000-10,000 nm diameter). A method that can separate intravascular versus extravascular NB signal is needed as an imaging biomarker for improved tumor detection. We present a demonstration of decorrelation time (DT) mapping for enhanced tumor NB-CEUS imaging. In vitro models validated the sensitivity of DT to agent motion. Prostate cancer mouse models validated in vivo imaging potential and sensitivity to cancerous tissue. Our findings show that DT is inversely related to NB motion, offering enhanced detail of NB dynamics in tumors, and highlighting the heterogeneity of the tumor environment. Average DT was high in tumor regions (~9 s) compared to surrounding normal tissue (~1 s) with higher sensitivity to tumor tissue compared to other mapping techniques. Molecular NB targeting to tumors further extended DT (11 s) over non-targeted NBs (6 s), demonstrating sensitivity to NB adherence. From DT mapping of in vivo NB dynamics we demonstrate the heterogeneity of tumor tissue while quantifying extravascular NB kinetics and delineating intra-tumoral vasculature. This new NB-CEUS-based biomarker can be powerful in molecular US imaging, with improved sensitivity and specificity to diseased tissue and potential for use as an estimator of vascular permeability and the enhanced permeability and retention (EPR) effect in tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- NHLBI NIH HHS
- NIBIB NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- National Institute of Biomedical Imaging and Bioengineering
- National Institute of General Medical Sciences
- National Heart, Lung, and Blood Institute
Zitieren
APA
Wegierak, D., Cooley, M. B., Perera, R., Wulftange, W. J., Gurkan, U. A., Kolios, M. C., & Exner, A. A. (2024). Decorrelation Time Mapping as an Analysis Tool for Nanobubble-Based Contrast Enhanced Ultrasound Imaging. IEEE Transactions on Medical Imaging. https://doi.org/10.1109/tmi.2024.3364076
Vancouver
Wegierak D, Cooley MB, Perera R, Wulftange WJ, Gurkan UA, Kolios MC, et al. Decorrelation Time Mapping as an Analysis Tool for Nanobubble-Based Contrast Enhanced Ultrasound Imaging. IEEE Transactions on Medical Imaging. 2024. doi:10.1109/tmi.2024.3364076
BibTeX
@article{Wegierak2024,
author = {Wegierak, Dana and Cooley, Michaela B and Perera, Reshani and Wulftange, William J and Gurkan, Umut A and Kolios, Michael C and Exner, Agata A},
title = {Decorrelation Time Mapping as an Analysis Tool for Nanobubble-Based Contrast Enhanced Ultrasound Imaging},
journal = {IEEE Transactions on Medical Imaging},
year = {2024},
doi = {10.1109/tmi.2024.3364076}
}
EUVIMED